Defectively N-glycosylated and non-O-glycosylated aminopeptidase N (CD13) is normally expressed at the cell surface and has full enzymatic activity

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Defectively N-glycosylated and non-O-glycosylated aminopeptidase N (CD13) is normally expressed at the cell surface and has full enzymatic activity. / Norén, K; Hansen, Gert Helge; Clausen, H; Norén, Ove; Sjöström, H; Vogel, L K.

I: Experimental Cell Research, Bind 231, Nr. 1, 1997, s. 112-8.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Norén, K, Hansen, GH, Clausen, H, Norén, O, Sjöström, H & Vogel, LK 1997, 'Defectively N-glycosylated and non-O-glycosylated aminopeptidase N (CD13) is normally expressed at the cell surface and has full enzymatic activity', Experimental Cell Research, bind 231, nr. 1, s. 112-8. https://doi.org/10.1006/excr.1996.3455

APA

Norén, K., Hansen, G. H., Clausen, H., Norén, O., Sjöström, H., & Vogel, L. K. (1997). Defectively N-glycosylated and non-O-glycosylated aminopeptidase N (CD13) is normally expressed at the cell surface and has full enzymatic activity. Experimental Cell Research, 231(1), 112-8. https://doi.org/10.1006/excr.1996.3455

Vancouver

Norén K, Hansen GH, Clausen H, Norén O, Sjöström H, Vogel LK. Defectively N-glycosylated and non-O-glycosylated aminopeptidase N (CD13) is normally expressed at the cell surface and has full enzymatic activity. Experimental Cell Research. 1997;231(1):112-8. https://doi.org/10.1006/excr.1996.3455

Author

Norén, K ; Hansen, Gert Helge ; Clausen, H ; Norén, Ove ; Sjöström, H ; Vogel, L K. / Defectively N-glycosylated and non-O-glycosylated aminopeptidase N (CD13) is normally expressed at the cell surface and has full enzymatic activity. I: Experimental Cell Research. 1997 ; Bind 231, Nr. 1. s. 112-8.

Bibtex

@article{42f59350e3bc11ddbf70000ea68e967b,
title = "Defectively N-glycosylated and non-O-glycosylated aminopeptidase N (CD13) is normally expressed at the cell surface and has full enzymatic activity",
abstract = "In order to study the effects of the absence of O-glycosylation and modifications of N-glycosylation on a class II membrane protein, pig and human aminopeptidase N (CD13) were stably expressed in the ldl(D) cell line. This cell line carries a UDP-Gal/UDP-GalNAc-epimerase deficiency which blocks the conversion of glucose into galactose derivatives. Thus it is possible in the ldl(D) cell line to selectively block O-glycosylation by the omission of N-acetylgalactoseamine from the culture medium and to alter N-glycosylation by the omission of galactose. In this way selectively altered glycosylated forms of the glycoprotein aminopeptidase N can be synthesized and the effects of altered glycosylation can be studied. It is demonstrated that aminopeptidase N carries {"}mucin-type{"} O-glycans and that this is predominantly located in the stalk, which connects the catalytic headgroup to the membrane anchor. Normally glycosylated aminopeptidase N is present in the plasma membrane of the ldl(D) cells. This is also the case for the non-O-glycosylated and defectively N-glycosylated forms. This is in line with the finding that the intracellular transport APN is unaffected by the absence of O-glycosylation or by changes in N-glycosylation as the various glycosylated forms of aminopeptidase N are normally converted from the high-mannose form to the complex glycosylated form. Enzymatic activity is not influenced by the changes in glycosylation.",
author = "K Nor{\'e}n and Hansen, {Gert Helge} and H Clausen and Ove Nor{\'e}n and H Sj{\"o}str{\"o}m and Vogel, {L K}",
note = "Keywords: Animals; Antigens, CD13; Biological Transport; Cell Line; Cell Membrane; DNA, Complementary; Glycosylation; Humans; Polysaccharides; Swine; Transfection",
year = "1997",
doi = "10.1006/excr.1996.3455",
language = "English",
volume = "231",
pages = "112--8",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press",
number = "1",

}

RIS

TY - JOUR

T1 - Defectively N-glycosylated and non-O-glycosylated aminopeptidase N (CD13) is normally expressed at the cell surface and has full enzymatic activity

AU - Norén, K

AU - Hansen, Gert Helge

AU - Clausen, H

AU - Norén, Ove

AU - Sjöström, H

AU - Vogel, L K

N1 - Keywords: Animals; Antigens, CD13; Biological Transport; Cell Line; Cell Membrane; DNA, Complementary; Glycosylation; Humans; Polysaccharides; Swine; Transfection

PY - 1997

Y1 - 1997

N2 - In order to study the effects of the absence of O-glycosylation and modifications of N-glycosylation on a class II membrane protein, pig and human aminopeptidase N (CD13) were stably expressed in the ldl(D) cell line. This cell line carries a UDP-Gal/UDP-GalNAc-epimerase deficiency which blocks the conversion of glucose into galactose derivatives. Thus it is possible in the ldl(D) cell line to selectively block O-glycosylation by the omission of N-acetylgalactoseamine from the culture medium and to alter N-glycosylation by the omission of galactose. In this way selectively altered glycosylated forms of the glycoprotein aminopeptidase N can be synthesized and the effects of altered glycosylation can be studied. It is demonstrated that aminopeptidase N carries "mucin-type" O-glycans and that this is predominantly located in the stalk, which connects the catalytic headgroup to the membrane anchor. Normally glycosylated aminopeptidase N is present in the plasma membrane of the ldl(D) cells. This is also the case for the non-O-glycosylated and defectively N-glycosylated forms. This is in line with the finding that the intracellular transport APN is unaffected by the absence of O-glycosylation or by changes in N-glycosylation as the various glycosylated forms of aminopeptidase N are normally converted from the high-mannose form to the complex glycosylated form. Enzymatic activity is not influenced by the changes in glycosylation.

AB - In order to study the effects of the absence of O-glycosylation and modifications of N-glycosylation on a class II membrane protein, pig and human aminopeptidase N (CD13) were stably expressed in the ldl(D) cell line. This cell line carries a UDP-Gal/UDP-GalNAc-epimerase deficiency which blocks the conversion of glucose into galactose derivatives. Thus it is possible in the ldl(D) cell line to selectively block O-glycosylation by the omission of N-acetylgalactoseamine from the culture medium and to alter N-glycosylation by the omission of galactose. In this way selectively altered glycosylated forms of the glycoprotein aminopeptidase N can be synthesized and the effects of altered glycosylation can be studied. It is demonstrated that aminopeptidase N carries "mucin-type" O-glycans and that this is predominantly located in the stalk, which connects the catalytic headgroup to the membrane anchor. Normally glycosylated aminopeptidase N is present in the plasma membrane of the ldl(D) cells. This is also the case for the non-O-glycosylated and defectively N-glycosylated forms. This is in line with the finding that the intracellular transport APN is unaffected by the absence of O-glycosylation or by changes in N-glycosylation as the various glycosylated forms of aminopeptidase N are normally converted from the high-mannose form to the complex glycosylated form. Enzymatic activity is not influenced by the changes in glycosylation.

U2 - 10.1006/excr.1996.3455

DO - 10.1006/excr.1996.3455

M3 - Journal article

C2 - 9056417

VL - 231

SP - 112

EP - 118

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 1

ER -

ID: 9769917